Table. 2—

2 Crude and adjusted geometric mean nitric oxide levels in exhaled air(FE,NO; ppb) for doctor's diagnosed asthma, wheezing phenotypes, specific immunoglobulin (Ig)E and peripheral blood eosinophilia in the total study population

Include inhaled corticosteroidsExclude inhaled corticosteroids
nCrudeAdjusted (95% CI)#nCrudeAdjusted (95% CI)#
Doctor's diagnosed asthma −3907.97.9(7.6–8.2)3767.97.9(7.5–8.2)
Doctor's diagnosed asthma +398.98.8(7.7–10.0)1810.1§10.0§(8.3–12.1)
Never wheeze2257.98.0(7.5–8.4)2217.97.9(7.5–8.4)
Early transient wheeze1238.18.1(7.5–8.7)1148.18.0(7.4–8.7)
Late/persistent wheeze638.28.2(7.4–9.1)428.58.6(7.5–9.7)
Specific IgE −1947.87.8(7.3–8.2)1797.77.7(7.2–8.1)
Specific IgE +539.3ƒ9.5ƒ(8.5–10.6)479.1ƒ9.4ƒ(8.4–10.5)
Eosinophilia −1668.08.0(7.6–8.5)1537.97.9(7.4–8.4)
Eosinophilia +688.78.6(7.8–9.5)628.58.4(7.6–9.3)
Asthma − IgE −1787.77.7(7.3–8.2)1727.77.6(7.2–8.1)
Asthma − IgE +458.9##9.0¶¶(8.0–10.2)448.7##8.9¶¶(8.0–10.1)
Asthma + IgE −168.78.3(6.8–10.1)79.18.5(6.4–11.5)
Asthma + IgE +812.4¶¶12.8¶¶(9.6–17.0)317.7¶¶19.0¶¶(12.2–29.8)
  • #: Geometric mean FE,NO value (95% confidence interval (CI)) (ppb), adjusted for atopy of the mother, study region and symptoms of cold in the two weeks before FE,NO measurement; −: negative; +: positive; : p<0.10 as compared with geometric mean FE,NO in children without doctor's diagnosed asthma; §: p<0.05 as compared with geometric mean FE,NO in children without doctor's diagnosed asthma; ƒ: p<0.05 as compared with geometric mean FE,NO in children without specific IgE; ##: p<0.10 as compared with geometric mean FE,NO in children without asthma and without specific IgE; ¶¶: p<0.05 as compared with geometric mean FE,NO in children without asthma and without specific IgE.